Yushi Matsuo Selected Research

Rheumatoid Arthritis

1/2023	Therapeutic Effect of Colony Stimulating Factor 1 Receptor Kinase Inhibitor, JTE-952, on Methotrexate-Refractory Pathology in a Rat Model of Rheumatoid Arthritis.
1/2020	Pharmacological Properties of JTE-952, an Orally Available and Selective Colony Stimulating Factor 1 Receptor Kinase Inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yushi Matsuo Research Topics

Disease

3	Arthritis (Polyarthritis) 01/2023 - 01/2020
2	Rheumatoid Arthritis 01/2023 - 01/2020
2	Experimental Arthritis 01/2020 - 01/2020
2	Osteoporosis 10/2011 - 03/2011
1	Pain (Aches) 01/2023
1	Hyperalgesia 01/2023
1	Inflammation (Inflammations) 01/2020

Drug/Important Bio-Agent (IBA)

3	JTE-952IBA 01/2023 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2020
2	Macrophage Colony-Stimulating FactorIBA 01/2023 - 01/2020
2	Calcium-Sensing ReceptorsIBA 10/2011 - 03/2011
1	Therapeutic UsesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Antirheumatic Agents (DMARD)IBA 01/2023
1	LigandsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	JTT 305IBA 10/2011
1	Anabolic AgentsIBA 10/2011
1	Parathyroid Hormone (Parathormone)IBA 03/2011

Therapy/Procedure

1	Therapeutics 01/2020
1	Injections 03/2011